Position statement on routine laboratory testing before endoscopic procedures.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 18984097)

Published in Gastrointest Endosc on November 01, 2008

Authors

ASGE Standards of Practice Committee, Michael J Levy, Michelle A Anderson, Todd H Baron, Subhas Banerjee, Jason A Dominitz, S Ian Gan, M Edwyn Harrison, Steven O Ikenberry, Sanjay Jagannath, David Lichtenstein, Bo Shen, Robert D Fanelli, Leslie Stewart, Khalid Khan

Articles by these authors

The B73 maize genome: complexity, diversity, and dynamics. Science (2009) 18.73

Guideline for the management of ingested foreign bodies. Gastrointest Endosc (2002) 9.03

Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol (2006) 6.60

Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51

Management of ingested foreign bodies and food impactions. Gastrointest Endosc (2011) 6.08

Lesbian, gay, bisexual, and transgender-related content in undergraduate medical education. JAMA (2011) 5.65

Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A (2005) 5.05

Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol (2006) 4.70

Factors predictive of adverse events following endoscopic papillary large balloon dilation: results from a multicenter series. Dig Dis Sci (2012) 4.35

Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33

A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc (2006) 4.31

A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc (2010) 4.26

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol (2006) 4.22

The use of rapid indicators for the detection of organic residues on clinically used gastrointestinal endoscopes with and without visually apparent debris. Infect Control Hosp Epidemiol (2014) 3.96

Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83

Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc (2007) 3.59

Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol (2002) 3.41

Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology (2010) 3.24

Wireless capsule endoscopy. Gastrointest Endosc (2013) 3.21

Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst (2006) 3.18

Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol (2002) 3.13

ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc (2006) 3.12

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol (2004) 3.10

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut (2012) 3.09

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology (2004) 2.98

Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin Gastroenterol Hepatol (2013) 2.91

A phenylalanine in DGAT is a key determinant of oil content and composition in maize. Nat Genet (2008) 2.89

Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc (2009) 2.84

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology (2009) 2.75

Sedation and anesthesia in GI endoscopy. Gastrointest Endosc (2008) 2.73

Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol (2007) 2.73

The role of endoscopy in the management of obscure GI bleeding. Gastrointest Endosc (2010) 2.68

Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl (2005) 2.63

ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc (2006) 2.63

Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis. Dig Dis Sci (2014) 2.62

Complications of ERCP. Gastrointest Endosc (2012) 2.61

EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc (2007) 2.61

Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc (2003) 2.60

Establishing a true assessment of endoscopic competence in ERCP during training and beyond: a single-operator learning curve for deep biliary cannulation in patients with native papillary anatomy. Gastrointest Endosc (2007) 2.60

Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc (2010) 2.59

Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factors. Gastrointest Endosc (2010) 2.52

Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc (2014) 2.52

The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc (2014) 2.47

Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol (2010) 2.46

Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science (2012) 2.44

Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol (2003) 2.43

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol (2011) 2.38

Tissue adhesives: cyanoacrylate glue and fibrin sealant. Gastrointest Endosc (2013) 2.38

A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc (2010) 2.38

Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest Endosc (2008) 2.37

Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology (2003) 2.35

ASGE guideline: The role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc (2004) 2.33

A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med (2008) 2.31